Retinoblastoma and p53 protein expression in sporadic colorectal cancers

European Journal of Surgical Oncology

Volumn 24, Issue 5, 1998, Pages 436-439

  Chetty, R ^a   Subramoney, T ^a   Singh, J P ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

Cell cycle; Colorectal cancer; p53; Retinoblastoma

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL CYCLE; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CARCINOMA; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0031723792     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(98)92434-9     Document Type: Article

References (34)

1. Clurman BE. Roberts JM. Cell cycle and cancer. J Nail Cancer Inst 1995; 87: 1499-501.
2. Lee WH, Shew JY, Hong FD, et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642-5.
3. Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992; 84: 1251-6.
4. Constancia M, Seruca R, Carneiro F. Silva F, Castedo S. Retinoblastoma gene structure and product expression in human gastric carcinomas. Br J Cancer 1994; 70: 1018-24.
5. Cance WG, Brennan MF. Dudas ME, Huang C-M, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 1990; 323: 1457-62.
6. Holm R, Nesland JM. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol 1994; 172: 267-72.
7. Martinez JC, Piris MA, Sanchez-Beato M, et al. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki 67 growth fraction. J Pathol 1993; 169: 405-12.
8. Cordon-Cardo C, Richon VM. Expression of the retino-blastoma protein is regulated in normal human tissues. Am J Pathol 1994; 144: 500-10.
9. Xu H-J, Hu S-X, Benedict WF. Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total Rb protein level. Oncogene 1991; 6: 1139-46.
10. Bartek J, Bartkowa J, Vojtsek B, et al. Aberrant, expression of the p53 oncoprotein is a common feature in a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-703.
11. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-602.
12. Meling GI, Lothe RA, Borresen A-L, et al. Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytomelric analysis. Br J Cancer 1991; 6: 475-80.
13. Gope R, Christensen MA, Thorson A, et al. Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. J Natl Cancer Inst 1991; 82: 310-4.
14. Ali AA, Marcus JN, Harvey P, et al. RBI protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J 1993; 7: 931-7.
15. Fukuda K., Monden T, Yamamoto H, et al. Immunohistochemical study of retinoblastoma gene expression in coloreclal carcinomas. Int J Oncol 1994; 4: 117-21.
16. Yamamoto H, Monden T, Ikeda K. et al. Coexpression of cdk2/ cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995; 71: 1231-6.
17. Chetty R, Subramoney T, Singh JP, Harilal P. Retinoblastoma (pRb) protein expression in colorectal cancer. Anticancer Res 1997; 17: 2593-8.
18. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-51.
19. Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell 1990; 61: 759-67.
20. Bussey HJR. Familial Polyposis Coli: Family Studies. Histopathology. Differential Diagnosis, and Results of Treatment. Baltimore: The Johns Hopkins University Press, 1975: pp. 1-37.
21. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumour spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-49.
22. Bufill JA. Colorectal cancer. Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990; 113: 779-88.
23. Picksley SM, Lane DP. p53 and Rb: their cellular roles. Curr Opin Cell Biol 1994; 6: 853-8.
24. Presti JC, Reuter VE. Galan T, Fair WF, Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 1991; 51: 5405-9.
25. Ishikawa J. Xu H-J. Hu S-T, et al. Inactivation of the retinoblastoma gene in human bladder cancer and renal cell carcinomas. Cancer Res 1991; 51: 5736-7.
26. Varley JM, Armour J, Swallow JE, et al. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 1989; 4: 725-9.
27. Logothetis CJ, Xu H-J, Ro JY, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992; 84: 1256-61.
28. Xu H-J, Hu S-X, Cagle PT, Moore PT, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 1991; 51: 2735-9.
29. Kornblau SM, Xu H-J, Giglio A, et al. Clinical implications of altered retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res 1992; 52: 4587-90.
30. Batek J, Vojtesek B, Grand RJA, Gallimore PH, Lane DP. Cellular localization and T antigen binding of the retinoblasloma protein. Oncogene 1992; 7: 101-8.
31. Bookstein R, Rio P, Madreperla SA, et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci (USA) 1990; 87: 7762-6.
32. Jiang W, Zhang Y-J, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci (USA) 1993; 90: 9026-30.
33. Bosari S, Viale G, Roncalli M, et al. P53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 1995; 147: 790-8.
34. Bertorelle R, Esposito G, Del Mistro A, et al. Association of p53 gene and protein alterations with metastases in colorectal carcinoma. Am J Surg Pathol 1995; 19: 463-71.